Two New Studies Suggest Immune System Dysfunction Plays Role in Autism
Many medical professionals have long speculated that children with autism spectrum disorders (ASDs) are more prone to immune system dysfunction. Two new studies published in recent months have found a biological link between autism and immune system factors that could possibly lead to new treatment options.
Using a mouse model, researchers at the University of South Florida are studying the link between amyloid precursor protein (APP) and aberrations in the immune system. APP is best known for its role in Alzheimer’s disease. It is an integral membrane protein that is concentrated in the synapses of neurons (brain cells) and is used for formation and repair.
However, a specific fragment of APP known as sAPP-α has been found to be elevated in the blood of autistic children. This fragment is thought to play a role in T-cell immune responses. sAPP-α is also implicated as a factor in the excessive early brain growth seen with children with autism.
Research team leader Jun Tan MD PhD says that “There are reports of abnormal T-cell numbers and function in some persons affected with autism (but) no specific cause has been identified.” She also notes that the findings could potentially be used as an autism biomarker and medical diagnostic tests could be developed if the findings hold true in further studies, leading to an earlier diagnosis and more effective treatments.
Cytokines, the immune system’s messengers and regulators, was the focus of research conducted at the University of Kansas Medical Center. Cytokines and the immune system are active in many pathways that are shared by those that affect brain development and neurotransmission.
Researchers analyzed the plasma of 99 children with autism between the ages of 5 and 10 and compared the samples to those of 40 age- and gender-matched unrelated healthy siblings without an ASD. There are many different types of cytokines, but the focus of the study was specifically focused on 29 proteins.